
Hims & Hers Health, Inc.
HIMSHims & Hers Health, Inc. is a telehealth company that offers a range of healthcare and wellness products and services. It provides virtual consultations, prescription medications, and over-the-counter wellness products across categories such as mental health, dermatology, sexual health, and primary care, aiming to improve access and convenience in healthcare delivery.
Company News
The article recommends Amazon and Hims & Hers Health as top stocks to double up on in 2026. Amazon is positioned to benefit from AI-driven efficiency gains in its operations and AWS infrastructure, with potential to replace 600,000 positions through AI and robotics by 2033. Hims & Hers Health is highlighted for its growth potential in telehealth,...
The article identifies the top 10 most heavily shorted stocks in the market as of January 16, 2026, with short interest ranging from 36-56%. These stocks are highlighted as potential candidates for short squeezes, where unexpected price increases force short sellers to cover positions, creating rapid gains. The list includes Choice Hotels Interna...
Motley Fool contributors discuss investment opportunities for 2026 across three sectors: space companies (Rocket Lab, Redwire), healthcare/medtech (TransMedics Group), and telehealth disruption (Hims & Hers). The space sector is highlighted as a potential growth area with SpaceX's anticipated IPO, while healthcare picks focus on innovative busine...
The article identifies the top 10 most heavily shorted stocks as of December 29, 2025, led by Lucid Group with 54.51% short interest, followed by Choice Hotels and Avis Budget Group. Short sellers believe these companies are overvalued, while bullish traders view high short interest as potential short squeeze opportunities. The list includes stoc...
The article highlights five high short-interest stocks with potential for significant rebounds in early 2026, focusing on companies in AI, healthcare, and technology sectors that have strong growth prospects and are currently undervalued.


